High mobility group box 1 (HMGB1) quantified by ELISA that dose not cross-react with HMGB2

por Yakabe, K, Yamada, S, Kobayashi, M, Maruyama, I
Publicado 2005

Pathogenetic roles of Synoviolin in synovial hyperplasia of rheumatoid arthritis

por Yamasaki, S, Yagishita, N, Amano, T, Tsuchimochi, K, Maruyama, I, Nishioka, K, Nakajima, T
Publicado 2003

Transcriptional regulation of Synoviolin is important for the proliferation of rhumatoid synovial cells

por Tsuchimochi, K, Yamasaki, S, Yagishita, N, Amano, T, Komiya, S, Maruyama, I, Nishioka, K, Nakajima, T
Publicado 2003

The importance of Synoviolin in embryogenesis

por Yagishita, N, Amano, T, Yamasaki, S, Tsuchimochi, T, Nishioka, K, Maruyama, I, Fukamizu, A, Nakajima, T
Publicado 2003

Hyper-ERAD: a novel pathomechanism for rheumatoid arthritis

por Nakajima, T, Yagishita, N, Yamasaki, S, Tsuchimochi, K, Amano, T, Fukamizu, A, Maruyama, I, Nishioka, K
Publicado 2004

Synoviolin as a novel pathogenic factor for arthropathy

por Amano, T, Yamasaki, S, Yagishita, N, Tsuchimochi, K, Fukamizu, A, Maruyama, I, Nishioka, K, Nakajima, T
Publicado 2003

High mobility group box 1: as a 'testament' mediator

por Maruyama, I, Abeyama, K, Ito, T, Biswas, KK, Kawahara, K, Hashiguchi, T, Yakabe, K, Yamada, S, Wada, H
Publicado 2005

Fe-oxide concretions formed by interacting carbonate and acidic waters on Earth and Mars

por Yoshida, H., Hasegawa, H., Katsuta, N., Maruyama, I., Sirono, S., Minami, M., Asahara, Y., Nishimoto, S., Yamaguchi, Y., Ichinnorov, N., Metcalfe, R.
Publicado 2018